5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differences in ancestry and presence of gastric precursor lesions in individuals with young- and average-onset gastric cancer
    Journal Article

    Magahis, P. T.; Cornet, N.; Tang, L.; Arora, K.; Hingorani, N.; King, S.; Markowitz, A. J.; Schattner, M.; Shimada, S.; Maron, S. B.; more...
    Cancer Medicine (2024)

    Fulltext@MSK | Save
  • A novel JAK2 fusion in T-cell prolymphocytic leukemia
    Meeting Abstract

    Eren, O. C.; Stuver, R.; Zhou, T.; Zaidinski, M.; Moskowitz, A. J.; Horwitz, S. M.; Ewalt, M. D.; Zhang, Y.; Lim, M.
    Virchows Archiv (2024)

    Fulltext@MSK | Save
  • GBM AGILE platform trial for newly diagnosed and recurrent GBM: Results of first experimental arm, regorafenib
    Meeting Abstract

    Lassman, A.; Alexander, B.; Berry, D.; Buxton, M.; Cavenee, W.; Colman, H.; De Groot, J.; Ellingson, B.; Gordon, G.; Hyddmark, E. M. V.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (CTDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • CXCL1 mediates leptomeningeal metastasis growth
    Meeting Abstract

    Osman, A.; Remsik, J.; Wijetunga, A.; Snyder, J.; Manoranjan, B.; Nobre, A.; Freret, M.; Guber, D.; Chabot, K.; Piedrafita-Ortiz, S.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Global expansion of GBM AGILE: A phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Weller, M.; Berry, D.; Blondin, N.; Boulmay, B.; Buxton, M.; Chinot, O.; Colman, H.; de la Fuente, M.; de Groot, J.; Drappatz, J.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Perry, J. R.; Cloughesy, T.; Berry, D. A.; Buxton, M. B.; Colman, H.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Mellinghoff, I. K.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • CRISPR-Cas9 genetic targeting of metastatic pancreatic cancer
    Meeting Abstract

    Bowland, K.; Lai, J.; Teh, S. S. K.; Bennett, A.; Skaist, A.; Zhang, Y.; Thompson, E.; Wheelan, S. J.; Hruban, R. H.; Karchin, R.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Loss of heterozygosity is low for specific HLA alleles in cancer patients with driver mutations
    Meeting Abstract

    Roy, C.; Sewastianik, T.; Halvey, P.; Montesion, M.; Jindal, A.; Vallaster, M.; Lam, H.; Garrity, S.; Shapiro, G.; Klebanoff, C. A.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • THRIVE(TM) non-viral targeted transgene knock-in platform generates specific and potent TCR T cell products for the treatment of solid cancers
    Meeting Abstract

    Narayan, S.; Swanson, N.; Drain, A.; Gareau, K.; Rouillard, N.; Liang, J.; Liu, H. W.; Brown, L.; Lamothe, R.; Greenberg, P. D.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save